Systematic assessment of gamma hydroxybutyrate (GHB) effects during and after acute intoxication

American Journal on Addictions

Volumn 17, Issue 4, 2008, Pages 312-318

  Kim, Susan Y ^a   Barker, Judith C ^a   Anderson, Ilene B ^a   Dyer, Jo Ellen ^a   Earnest, Gillian ^b   Blanc, Paul D ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYBUTYRIC ACID;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CIGARETTE SMOKING; DISEASE ASSOCIATION; DRUG ABUSE; FEMALE; HUMAN; INFANT; INTOXICATION; MALE; NEWBORN; QUESTIONNAIRE; RISK FACTOR; SYMPTOM;

ADJUVANTS, ANESTHESIA; ADULT; AFFECT; COGNITION; FEMALE; FOCUS GROUPS; HEALTH SURVEYS; HUMANS; INTERVIEWS AS TOPIC; MALE; MOTIVATION; PSYCHOMOTOR PERFORMANCE; QUESTIONNAIRES; SMOKING; SODIUM OXYBATE; SUBSTANCE-RELATED DISORDERS; UNITED STATES;

EID: 46849091951     PISSN: 10550496     EISSN: 15210391     Source Type: Journal    
DOI: 10.1080/10550490802138988     Document Type: Article

References (17)

1. Chin RL, Sporer KA, Cullison B, et al. Clinical course of gamma-hydroxybutyrate overdose. Ann Emerg Med. 1998;31:716-722.
2. Galloway GP, Frederick SL, Staggers FE, et al. Gamma-hydroxybutyrate: An emerging drug of abuse that causes physical dependence. Addiction. 1997;92:89-96.
3. Gonzalez A, Nutt DJ. Gamma hydroxybutyrate abuse and dependency. J Psychopharmacol. 2005;19:195-204.
4. Miotto K, Darakjian J, Basch J, et al. Gamma-hydroxybutric acid: patterns of use, effects and withdrawal. Am J Addict. 2001;10:232-241.
5. Dyer JE, Anderson IB, Kim SY, et al. Designing a gamma hydroxybutyrate (GHB) structured telephone-administered survey instrument. Journal of Medical Toxicology. 2007;3:7-14.
6. Microsoft® Word 2004 for Mac. Version 11.3.5 (070413). Proofing Tools. Redmond, WA: Microsoft Corporation.
7. Barker JC, Harris S, Dyer JE. Experiences of gamma hydroxybutyrate (GHB) ingestion: A focus group study. J Psychoactive Drugs. 2007:39;115-129. (Erratum to be published).
8. Kim SY, Anderson IB, Dyer JE, et al. High-risk behaviors and hospitalizations among gamma hydroxybutyrate (GHB) users. Am J Drug Alcohol Abuse. 2007;33:429-438.
9. Snead OC, Gibson KM. Gamma-hydroxybutyric acid. NEJM. 2005:352;2721-2732.
10. McCabe SE, Brower KJ, West BT, et al. Trends in non-medical use of anabolic steroids by U.S. college students: Results from four national surveys. Drug Alcohol Depend. 2007;90:243-251.
11. Bingham CR, Elliott MR, Shope JT. Social and behavioral characteristics of young adult drink/drivers adjusted for level of alcohol use. Alcohol Clin Exp Res. 2007:31:655-664.
12. Paterson NE, Froestl W, Markou A. The GABA B receptor agonists baclofen and CGP44532 decreased nicotine self-administration in the rat. Psychopharmacology (Berl). 2004;172:179-186.
13. Li SP, Park MS, Kim JH, et al. Chronic nicotine and smoke treatment modulate dopaminergic activities in ventral tegmental area and nucleus accumbens and the gamma-aminobutyric acid type B receptor expression of the rat prefrontal cortex. J Neurosci Res. 2004;78: 868-879.
14. Fadda P, Scherma M, Fresu A, et al. Baclofen antagonizes nicotine-, cocaine-, and morphine-induced dopamine release in the nucleus accumbens of rat. Synapse. 2003;501:1-6.
15. Markou A, Paterson NE, Semenova S. Role of gamma-aminobutyric acid (GABA) andmetabotropic glutamate receptors in nicotine reinforcement: Potential pharmacotherapies for smoking cessation. Ann NY Acad Sci. 2004;1025:491-503.
16. Cousins MS, Stamat HM, de Wit H. Effects of a single dose of baclofen on self-reported subjective effects and tobacco smoking. Nicotine Tob Res. 2001;3:123-129.
17. Moriya F, Nishimura H, Furumiya J, et al. Effects of drinking and smoking on endogenous levels of urinary gamma-hydroxybutyric acid, a preliminary study. Leg Med (Tokyo). 2006;8:231-234.